Natural Killer Cells in Allogeneic Transplantation: Effect on Engraftment, Graft- versus-Tumor, and Graft-versus-Host Responses
Open Access
- 31 July 2009
- journal article
- review article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 15 (7), 765-776
- https://doi.org/10.1016/j.bbmt.2009.01.019
Abstract
No abstract availableKeywords
This publication has 120 references indexed in Scilit:
- Accelerated tumor growth in mice deficient in DNAM-1 receptorThe Journal of Experimental Medicine, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- Natural killer cell–directed therapies: moving from unexpected results to successful strategiesNature Immunology, 2008
- NKG2D-Deficient Mice Are Defective in Tumor Surveillance in Models of Spontaneous MalignancyImmunity, 2008
- Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myelomaBlood, 2008
- Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCTBlood, 2007
- Regulation of Activated CD4+ T Cells by NK Cells via the Qa-1–NKG2A Inhibitory PathwayImmunity, 2007
- Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15Immunity, 2007
- In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infectionImmunology, 2007
- Identification, activation, and selectivein vivoablation of mouse NK cells via NKp46Proceedings of the National Academy of Sciences of the United States of America, 2007